Evidence map›Paper›PMID 26398198›Full record

ArticleJournal of proteome research2015

SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex.

Yelenis Mari, Graham M West, Catherina Scharager-Tapia, Bruce D Pascal, Ruben D Garcia-Ordonez, Patrick R Griffin

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yelenis MariDepartment of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Graham M WestDepartment of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Catherina Scharager-TapiaDepartment of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Bruce D PascalDepartment of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Ruben D Garcia-OrdonezDepartment of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Patrick R GriffinDepartment of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Scripps Research Institute · US

Funding

UHTS Implementation(Florida)U54MH084512 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI ROSEN, HUGH · 2008 to 2013
$89.2M
Development of HTS assays to discover modulators of LRH-1R01CA134873 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI GRIFFIN, PATRICK ROBERT · 2010 to 2012
$1.2M
NCI NIH HHS CA134873NCI NIH HHS R01 CA134873NIMH NIH HHS MH084512NIMH NIH HHS U54 MH084512
6 · The paper itself

Abstract

Liver receptor homologue-1 (LRH1) is an orphan nuclear receptor that has been shown to play a role in the transcriptional regulation of pathways involved in cancer. Elucidating the components of the LRH1 transcriptional complex to better understand endogenous regulation of the receptor as well as its role in cancer remains a high priority. A sub-cellular enrichment strategy coupled with proteomic approaches was employed to identify putative LRH1 co-regulators. Nuclear fractionation protocol was essential for detection of LRH1 peptides by mass spectrometry (MS), with most peptides being observed in the insoluble fraction (receptor bound to DNA). SERBP1 and ILF3 were identified as LRH1 interacting partners by both Western blot and MS/MS analysis. Receptor knockdown by siRNA showed an increase in SERBP1 expression, while ILF3 expression was unchanged. In contrast, receptor overexpression decreased only SERBP1 mRNA levels. Consistent with these data, in a promoter:reporter assay, binding of LRH1 to the promoter region of SERBP1 resulted in a decrease in the expression level of the reporter gene, subsequently inhibiting transcription. Given the receptor's role in cancer progression, the study here elucidates additional transcriptional machinery involved in LRH1 signaling and potentially provides new targets for therapeutics development.

Indexed as

Gene Expression RegulationTranscription, GeneticAmino Acid SequenceCell Line, TumorCell NucleusChemical FractionationHEK293 CellsHepatocytesHumansMolecular Sequence AnnotationMolecular Sequence DataNuclear Factor 90 ProteinsPeptidesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPlasmidsPromoter Regions, GeneticILF3 protein, humanNR5A2 protein, humanNuclear Factor 90 ProteinsPeptidesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPPARGC1A protein, humanPRMT1 protein, humanProtein-Arginine N-MethyltransferasesReceptors, Cytoplasmic and NuclearRecombinant ProteinsRepressor ProteinsRNA-Binding ProteinsRNA, Small InterferingSERBP1 protein, humanTranscription Factorsinterleukin enhancer binding factor-3 (ILF3)liver receptor homologue-1 (LRH1; NR5A2)nuclear receptorperoxisome proliferator-activated receptor γ co-activator-1α (PGC1α)protein arginine methyltransferase 1 (PRMT1)SERPINE1 mRNA binding protein-1 (SERBP1)

Identifiers

PMID26398198
PMCPMC5178129
OpenAlexW2219260350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.